This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Stroke, Volume 56, Issue Suppl_1 , Page AWP56-AWP56, February 1, 2025. Introduction:Prior studies have shown the association between oral infection, white matter hyperintensity (WMH), a marker of cerebral small vessel disease (CSVD), and asymptomatic intracranial atherosclerosis (ICAS). CSVD was assessed using the log of WMH volume.
On-demand access is available now and will remain open until December 2025. Dyslipidemia, Atherosclerosis & Thrombosis: Explore non-statin therapies, strategies for managing hypertriglyceridemia, and new guidance on lipoprotein(a) management. When Will It Be Available? Ready to Access CMHC On-Demand?
Stroke, Volume 56, Issue Suppl_1 , Page AWP292-AWP292, February 1, 2025. Background:Intracranial atherosclerosis (ICAS) is a common stroke cause, with a recurrent stroke risk of up to 18% per year despite treatment advances. Hypertension was present in 74% of the intervention group and 71% of controls. months (IQR 9.75-25.5).
Keynote speaker and atherosclerosis expert Peter Libby, MD , captivated the audience with an update on his research into inflammation and atherosclerosis. He discussed therapeutic options not only for treating atherosclerosis but also for preventing cardiovascular disease. Learn more now!
Stroke, Volume 56, Issue Suppl_1 , Page AWP293-AWP293, February 1, 2025. The HR was nonsignificant after adjustment for age, gender, race, hypertension, diabetes, hypercholesterolemia and smoking status, adjusted HR 1.33 The HR remained significant after adjustment for age, gender and race, adjusted HR 1.72 with a 95% CI of 1.17-2.51.
Stroke, Volume 56, Issue Suppl_1 , Page AWP281-AWP281, February 1, 2025. The model consisted of six variables, and one point was awarded for each: atrial fibrillation, large artery atherosclerosis, large vessel occlusion, obesity, prior anti-hypertensive medication usage and if patients age was 18-39 or > 69.
Stroke, Volume 56, Issue Suppl_1 , Page ATP288-ATP288, February 1, 2025. Carotid atherosclerosis (CAS) is a critical precursor to atherosclerotic cardiovascular disease and is closely associated with the development and progression of conditions such as stroke and poor prognosis. 2021-KY-1289-001).Results:Among respectively.
Stroke, Volume 56, Issue Suppl_1 , Page AWP336-AWP336, February 1, 2025. Background:Trimethylamine N-oxide (TMAO), a gut microbiome-derived metabolite trimethylamine-containing nutrients, is mechanistically linked to atherosclerosis progression and platelet aggregation, leading to cardiovascular disease.
Stroke, Volume 56, Issue Suppl_1 , Page A135-A135, February 1, 2025. We aimed to evaluate the association between carotid artery tortuosity and the incidence of ischemic stroke.Methods:We analyzed 3D contrast-enhanced MRA datasets from 2,066 participants enrolled in the Atherosclerosis Risk in Communities (ARIC) Carotid MRI study.
Stroke, Volume 56, Issue Suppl_1 , Page A102-A102, February 1, 2025. Background and Purpose:Chronic kidney disease (CKD) is associated with an increased risk of stroke and worse outcomes, yet it is often asymptomatic, with an estimated 90% of individuals unaware they have CKD until its later stages. female, 22.1% female, 22.1%
Stroke, Volume 56, Issue Suppl_1 , Page AWP388-AWP388, February 1, 2025. Introduction:Eicosanoids (EIC) are lipid mediators that play a systemic role in inflammation and, more specifically, in the brain, contribute to the process of neurovascular coupling. Results:Among the 9,444 participants included, the mean age was 57 (5.7 SD), and 43.2%
Stroke, Volume 56, Issue Suppl_1 , Page ATMP107-ATMP107, February 1, 2025. 1.98), hypertension (OR: 1.29, 95% CI: 1.02-1.61), Objective:Late-life vascular health and cerebrovascular disease have been identified as potential risk factors for late-life depression (LLD). At midlife, 20.2% had 0 VRFs, 41.3% had 1 VRF, 27.2%
Stroke, Volume 56, Issue Suppl_1 , Page AWMP18-AWMP18, February 1, 2025. CMBs in lobar regions suggest cerebral amyloid angiopathy (CAA), which is sometimes accompanied by superficial siderosis (SS), while subcortical CMBs indicate hypertensive origins. CMB and SS presence and location were coded from T2* GRE sequences.
Stroke, Volume 56, Issue Suppl_1 , Page AWMP24-AWMP24, February 1, 2025. Background:Cerebral autonomic regulation is measurable through heart rate variability (HRV). Low HRV (L-HRV) is linked to an increased risk for ischemic stroke. However, limited studies have investigated the link between L-HRV and WMH.
Stroke, Volume 56, Issue Suppl_1 , Page AWP310-AWP310, February 1, 2025. Smoking, diabetes, hypertension, obesity, Black race, age, low education, male sex, and APOEe4 were associated with an increased risk of dementia/no PD. Midlife current smoking (HR 0.41, 95% CI 0.18-0.95,
AHA announced a $12M investment in AI research, with an RFP slated for early 2025. Many of our CMHC faculty who spoke at AHA 2024 are featured in this on-demand program, sharing expertise on key topics in cardiorenal health, obesity, diabetes, dyslipidemia, atherosclerosis, and more. Read the published study. Watch AI-ECHO results.
Lancet Commission on Obesity: The Lancet Diabetes & Endocrinology journal has accepted the Lancet Commission on Obesity’s report for publication, scheduled for early 2025, announced Robert H. Eckel, MD, FAHA, FACC at the 19th Annual CMHC.
Attendees, including hundreds of health professionals, gained access to the latest knowledge and developments in the field, from exclusive insights from one of the foremost authorities on atherosclerosis, Dr. Peter Libby, to innovations like new therapeutic agents and exciting advancements in renal protection. In the U.S.,
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content